Acadia Healthcare (ACHC) Tops Q4 EPS by 13c

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.81, $0.13 better than the analyst estimate of $0.68. Revenue for the quarter came in at $593.5 million versus the consensus estimate of $588.05 million.

GUIDANCE:

Acadia Healthcare sees FY2022 EPS of $2.85-$3.15, versus the consensus of $2.91. Acadia Healthcare sees FY2022 revenue of $2.55-2.6 billion, versus the consensus of $2.48 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Hermès can regain momentum despite China weakness, Jefferies says